Truth meets the eye!! Eye-tracking method sheds new light on mechanics of hypochondriasis.

Written By :  Dr. Shivi Kataria
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-04-09 00:31 GMT   |   Update On 2021-04-09 00:31 GMT

World Journal of Psychiatry has reported in a recent study that illness-related information processing biases appear to be a robust feature of Illness anxiety disorder (IAD)-commonly called as hypochondriasis and may have an important role in explaining the etiology and maintenance of the disorder.IAD is a common, distressing, and debilitating condition, with the key feature being a...

Login or Register to read the full article

World Journal of Psychiatry has reported in a recent study that illness-related information processing biases appear to be a robust feature of Illness anxiety disorder (IAD)-commonly called as hypochondriasis and may have an important role in explaining the etiology and maintenance of the disorder.

IAD is a common, distressing, and debilitating condition, with the key feature being a persistent conviction of the possibility of having one or more serious or progressive physical disorders. It has been argued that the dysfunctional beliefs about illness and misinterpretation of bodily symptoms appear to be specific and important for patients with IAD and to be a highly specific characteristic of IAD.

Because eye movements are guided by visual-spatial attention, eye-tracking technology is a comparatively direct, continuous measure of attention direction and speed when stimuli are oriented. Researchers have tried to identify selective visual attention biases by tracking eye movements within dot-probe paradigms because dot-probe paradigm can distinguish these attentional biases more clearly.

The study was designed to record eye movements of individuals with IAD and healthy controls while participants viewed a set of pictures from four categories (illness-related, socially threatening, positive, and neutral images). Biases in initial orienting were assessed from the location of the initial shift in gaze, and biases in the maintenance of attention were assessed from the duration of gaze that was initially fixated on the picture per image category.

The eye movement of the participants in the IAD group was characterized by an avoidance bias in initial orienting to illness-related pictures. There was no evidence of individuals with IAD spending significantly more time viewing illness-related images compared with other images. Patients with IAD had an attention bias at the early stage and overall attentional avoidance. In addition, this study found that patients with significant anxiety symptoms showed attention bias in the late stages of attention processing.

This is the first study which has examined patients with IAD having an attention bias that is mainly manifested as attentional avoidance at the early stage and overall attentional maintenance when presented with illness-related stimuli. They also have demonstrated vigilance of attention at the early attention stage and overall attentional maintenance when presented with disease and positive/neutral stimuli.

In addition, this study found that patients with suspected disorders with significant anxiety symptoms show attention bias in the late stage of attention processing and struggle to dismiss the stimulus, showing delayed detachment.

This study suggests that patients with IAD have attention bias and this may have provided a new way of identification of IAD symptoms using an eye-tracking evaluation method.

Source: Zhang YB, Wang PC, Ma Y, Yang XY et al. Using eye movements in the dot-probe paradigm to investigate attention bias in illness anxiety disorder. World J Psychiatr 2021; 11(3): 73-86 URL: https://www.wjgnet.com/2220-3206/full/v11/i3/73.htm

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News